NCT07155759View on ClinicalTrials.gov

Long-term Outcomes of Prostate Cancer Screening

NAActive, not recruitingINTERVENTIONAL
Enrollment

7,500

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

November 30, 2035

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

PSA/Stockholm3/MRI

Stockholm3+PSA followed by MRI of the prostate

DIAGNOSTIC_TEST

PSA

PSA followed by standard biopsies

Trial Locations (1)

Unknown

Karolinska Institutet, Stockholm

All Listed Sponsors
collaborator

Swedish Cancer Foundation

OTHER

collaborator

The Swedish Research Council

OTHER_GOV

lead

Karolinska Institutet

OTHER

NCT07155759 - Long-term Outcomes of Prostate Cancer Screening | Biotech Hunter | Biotech Hunter